Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1999
10/06/1999EP0946726A2 A variant human alpha-7 acetylcholine receptor subunit, and methods of production and use thereof
10/06/1999EP0946725A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
10/06/1999EP0946724A2 POLYPEPTIDES OF THE "BASIC-HELIX-LOOP-HELIX" bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946721A1 Human growth gene and short stature gene region
10/06/1999EP0946719A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
10/06/1999EP0946717A1 Transgenic plants expressing assembled secretory antibodies
10/06/1999EP0946715A1 Modified protein c and methods of use thereof
10/06/1999EP0946713A1 Method for in vitro preconditioning of myoblasts before transplantation
10/06/1999EP0946596A1 Peptide derivatives
10/06/1999EP0946595A2 Melanocortins
10/06/1999EP0946594A2 Enteric neural peptide
10/06/1999EP0946593A1 Use of polypeptides for treating thrombocytopenia
10/06/1999EP0946592A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/06/1999EP0946590A2 Dihydroxypropyl cysteine peptide and agent containing this peptide
10/06/1999EP0946589A1 Inhibitors of peptide binding to mhc class ii proteins
10/06/1999EP0946588A1 Use of dipeptide derivatives
10/06/1999EP0946502A1 Sulfonamide interleukin-beta converting enzyme inhibitors
10/06/1999EP0946501A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
10/06/1999EP0946205A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
10/06/1999EP0946201A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
10/06/1999EP0946199A1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW
10/06/1999EP0946196A1 Method for treating symptoms of diabetes
10/06/1999EP0946192A1 Uses of thioredoxin
10/06/1999EP0946191A1 Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity
10/06/1999EP0946190A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
10/06/1999EP0946189A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
10/06/1999EP0946188A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
10/06/1999EP0946185A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
10/06/1999EP0946178A1 Combination therapy for reducing the risks associated with cardiovascular disease
10/06/1999EP0946169A2 Method of producing a sustained-release preparation
10/06/1999EP0946167A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
10/06/1999EP0946166A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
10/06/1999EP0832900A4 Peptide and method of obtaining it
10/06/1999EP0779933A4 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
10/06/1999EP0517815B1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE
10/06/1999CN1230993A Expression vectors, cells, and methods for preparing thrombopoietin polypeptides
10/06/1999CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation
10/06/1999CN1230967A Process for producing plasma protein-containing medicament
10/06/1999CN1230966A Use of leptin antagonists for treating insulin resistance in type II diabetes
10/06/1999CN1230893A Assembly-deficient herpesvirus vaccine
10/06/1999CN1230892A Use of proteins as agents against autoimmune diseases
10/06/1999CN1230891A Lectin compositions and uses thereof
10/06/1999CN1230889A Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
10/06/1999CN1230436A Soluble recombined human bone formation protein 2 used in treating hemospoietic dysfunction and function damage
10/06/1999CN1230400A Composition and production process of recombined human interferon Alpha 2a as suppository matrix
10/06/1999CN1045391C Oral delivery system
10/05/1999US5962673 Antisense agent 8 to 30 nucleobases in length; for diagnosis and treatment of asthma, myasthenia gravis, graves' disease, allograft rejection, psoriasis and others; antitumor/ antiproliferative/antidiabetic/antiarthritic agents
10/05/1999US5962672 Antisense modulation of RhoB expression
10/05/1999US5962671 Oligonucleotide which suppresses gene expression of factor associated with neutral sphingomyelinase activation; factor is is a mediator of tumor necrosis factor activation of that enzyme through a signal transduction pathway; gene therapy
10/05/1999US5962669 Nucleic acid encoding prion protein variant
10/05/1999US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides
10/05/1999US5962664 Psychosis protecting nucleic acid, peptides, compositions and method of use
10/05/1999US5962660 Compound which suppresses selectin-mediated cellular adhesion; for stable antiinflammatory agents with better bioavailability and greater activity which are easier to synthesize
10/05/1999US5962653 Methods of obtaining antiviral proteins and antiviral peptides from Nostoc ellipsosporum
10/05/1999US5962652 Antibodies to protein, FAF1
10/05/1999US5962651 Modified hemoglobin and its use as a component of an artificial blood substitute
10/05/1999US5962650 Oxygen-reduced aqueous solution of factor VIII
10/05/1999US5962647 Bovine interleukin-1β protein and amino acid sequence
10/05/1999US5962646 ATP synthase Fo subunit
10/05/1999US5962645 Antiproliferative factor from patients with interstitial cystitis
10/05/1999US5962644 Porcine CD34
10/05/1999US5962636 Peptides capable of modulating inflammatory heart disease
10/05/1999US5962635 Therapeutic compounds
10/05/1999US5962634 Peptide of 6 to 25 amino acids which modulates immunoglobulin e binding to fc epsilon receptor 1; for treatment and prophylaxis of graft vs host disease, allergic rhinitis, food allergies, atropic dermatitis, and allergic asthma
10/05/1999US5962633 There is a need in the art for inhibitors of cysteins proteases as these enzymes have been implicated in the formation of new foci of metastatic carcinoma.
10/05/1999US5962522 Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
10/05/1999US5962521 Prostate glands disorders
10/05/1999US5962506 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases
10/05/1999US5962502 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
10/05/1999US5962487 Picornaviral 3c protease inhibitors
10/05/1999US5962427 Targeting, transferring dna into mammalian repair cells
10/05/1999US5962420 Wound healing agents; drug delivery; crosslinking fibrin
10/05/1999US5962419 Nervous system disorders; brain disorders
10/05/1999US5962418 Factor VII-derived peptides
10/05/1999US5962417 Reducing activation of tyrosinase
10/05/1999US5962416 Somatotropin releasing compound for accelerating hoof growth in horses
10/05/1999US5962415 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
10/05/1999US5962414 Modified Bowman-Birk inhibitor
10/05/1999US5962413 Dysmenorrhea
10/05/1999US5962411 Human growth hormone variants and methods of administering same
10/05/1999US5962410 Fungicides, antiprotozoa agent
10/05/1999US5962409 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
10/05/1999US5962408 Disulphide-cyclo- H-Cys-Glu-Gln-Tyr-Cys-OH!, and its use in blood-clotting disorders
10/05/1999US5962407 Loloatin derivatives and analogs
10/05/1999US5962406 Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
10/05/1999US5962405 Storage-stable fibrinogen preparations
10/05/1999US5962404 Enzymatically-produced oligodendrocyte cytotoxic dimeric IL-2 factor
10/05/1999US5962321 Leukemia inhibitory factor from mammalian species and use thereof to enhance implantation and development of embryos
10/05/1999US5962313 Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
10/05/1999US5962312 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/05/1999US5962311 A method of targeting attachment of a short-shafted recombinant adenovirus to a cell so as to effect entry of the short-shafted recombinant adenovirus into the cell.
10/05/1999US5962303 The invention relates to polynucleotides and polypeptides of bacterial ?topoisomerase iii.?
10/05/1999US5962301 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
10/05/1999US5962300 Polynucleotide which encodes a polypeptide tumor suppressor; for diagnosis, prevention, and treatment of cancer, eczema, psoriasis, psoriasis, scleroderma, dermatitis, skin atrophy, and other skin disorders; anticarcinogenic agents
10/05/1999US5962299 Adding a salt buffer, a sodium salt, at least one amino acid, and albumin and/or nonionic surfactant to protein c or activated protein c; for storage stability of anticoagulant
10/05/1999US5962295 This invention relates to newly identified polynucleotides and polypeptides, and their production and uses, as well as their variants, agonists and antagonists, and their uses.
10/05/1999US5962269 Methods for producing antibodies which specifically bind to interleukin-9 receptor
10/05/1999US5962267 Proinsulin derivative and process for producing human insulin
10/05/1999US5962266 Protease inhibitor peptides
1 ... 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 ... 3163